Searchicon: search

MOMETAMAX® Otic Suspension

(Gentamicin Sulfate, Mometasone Furoate Monohydrate, and Clotrimazole, Otic Suspension)

icon: canine

Product Description

Reliable relief of discomfort and irritation for mild to moderate cases

A convenient once-daily, triple-combination treatment applied for 7 days for mild to moderate cases of otitis externa associated with susceptible strains of yeast and bacteria in dogs.

PRODUCT LABEL

OVERVIEW

TECHNICAL

Indications

MOMETAMAX® Otic Suspension is indicated for the treatment of otitis externa in dogs caused by susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Pseudomonas spp. [including P. aeruginosa], coagulase-positive staphylococci, Enterococcus faecalis, Proteus mirabilis, and beta-hemolytic streptococci).

Features and Benefits

ANTI-INFLAMMATORY ACTION

MOMETASONE FUROATE MONOHYDRATE

Reduces discomfort, redness and swelling1

Mometasone rapidly controls inflammation without adrenocortical suppression2

ANTIFUNGAL ACTIVITY

CLOTRIMAZOLE

Effective against dermal infections caused by susceptible strains of yeast (Malassezia pachydermatis)1

ANTIBACTERIAL EFFECT

GENTAMICIN

Effective against a wide variety of Gram-positive and Gram-negative bacteria1

Diseases/Parasites

Canine otitis externa

Description

Each gram of MOMETAMAX Otic Suspension contains gentamicin sulfate, equivalent to 3 mg gentamicin base; mometasone furoate monohydrate equivalent to 1 mg mometasone furoate; and 10 mg clotrimazole, in a mineral oil-based system containing a plasticized hydrocarbon gel.

Administration and Dosage

For 7.5 g, 15 g, and 30 g bottles:

  • Administer once daily for 7 days
  • 4 drops per ear for dogs < 30 lbs
  • 8 drops per ear for dogs = or > 30 lbs

For 215 g bottles:

  • Administer once daily for 7 days
  • 2 drops per ear for dogs < 30 lbs
  • 4 drops per ear for dogs = or > 30 lbs

Vehicle

  • Solution-like consistency with clear advantage
    • Colorless solution is easy to differentiate from exudate
    • Eliminates staining
  • Hydrocarbon formulation consistency facilitates easy counting of drops for proper dosing
  • Ensures prolonged contact at the site of infection

Supplied

MOMETAMAX Otic Suspension is available in 7.5 g, 15 g, 30 g, and 215 g plastic bottles.

Important Safety Information

Do not use MOMETAMAX® Otic Suspension in pregnant dogs. The use of these components has been associated with deafness or partial hearing loss in a small number of sensitive dogs (e.g., geriatric), although it is usually temporary. If hearing or vestibular dysfunction is noted, discontinue use immediately and flush the ear canal thoroughly with a non-ototoxic solution. If hypersensitivity to any of the components occurs, treatment should be discontinued and appropriate therapy instituted. Concomitant use of drugs known to induce ototoxicity should be avoided. Do not use in dogs with known tympanic perforation. Administration of recommended doses beyond 7 days may result in delayed wound healing. Avoid ingestion. Keep out of the reach of children. For complete safety information, refer to the product label.

References

  1. Mometamax® Otic Suspension [gentamicin sulfate, mometasone furoate monohydrate, clotrimazole] [Product Information]. Madison, NJ: Intervet Inc.; 2021.
  2. Reeder CJ, Griffin CE, Polissar NL, et al. Comparative adrenocortical suppression in dogs with otitis externa following topical otic administration of four different corticosteroid-containing medications. Vet Ther. 2008;9:111-121.